Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Covington
Cantor Fitzgerald
Daiichi Sankyo
Teva
Cipla
Queensland Health
Johnson and Johnson

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091561

« Back to Dashboard

NDA 091561 describes CALCIUM ACETATE, which is a drug marketed by Amneal Pharms, Chartwell Rx, Eci Pharms Llc, Heritage Pharms Inc, Invagen Pharms, Lupin Ltd, Nostrum Labs Inc, West-ward Pharms Int, and Paddock Llc, and is included in twelve NDAs. It is available from twenty-eight suppliers. Additional details are available on the CALCIUM ACETATE profile page.

The generic ingredient in CALCIUM ACETATE is calcium acetate. There are two hundred and seventy-five drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
Summary for 091561
Tradename:CALCIUM ACETATE
Applicant:Paddock Llc
Ingredient:calcium acetate
Patents:0
Therapeutic Class:Genitourinary Agents
Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Pharmacology for NDA: 091561
Suppliers and Packaging for NDA: 091561
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CALCIUM ACETATE calcium acetate TABLET;ORAL 091561 ANDA Paddock Laboratories, LLC 0574-0113 N 0574-0113-02
CALCIUM ACETATE calcium acetate TABLET;ORAL 091561 ANDA Safecor Health, LLC 48433-300 N 48433-300-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength667MG
Approval Date:Apr 13, 2011TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
UBS
QuintilesIMS
Harvard Business School
Cipla
Healthtrust
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.